Characteristic | Recruited participants (n = 20) |
---|---|
Sociodemographic | |
 Age, mean (SD), yr | 38.40 (9.87) |
 Female | 16 (80) |
 English/Welsh/Scottish/N Irish/British | 19 (95) |
 University degree or higher | 13 (65) |
Employment status | |
 Employed full-time | 10 (50) |
 Employed part-time | 2 |
 Full- or part-time education | 2 |
 Full-time domestic | 1 (5) |
 Retired | 1 (5) |
 Unemployed | 4 (20) |
Relationship status | |
 Married/civil partnership | 9 (45) |
 Living with partner | 5 (25) |
 Divorced | 1 (5) |
 Single | 5 (25) |
Clinical | |
 Diagnosis (CD/UC/IBD-U) | 16 (80)/4 (20)/0 (0) |
 Disease duration mean (SD) (yrs) | 13.20 (10.46) |
 Faecal calprotectin mean (SD) ug/g | 175.69 (205.69) |
IBD medication | |
 5-ASA | 6 (30) |
 Thiopurines | 4 (20) |
 Anti-TNF (infliximab/adalimumab) | 3 (15)/4 (20) |
 Vedolizumab | 1 (5) |
 Steroids (methotrexate/budesonide/prednisolone) | 3 (15) /3 (15) /2 (10) |
 Ustekinumab | 5 (25) |
 None | 2 (10) |
 Previous surgery | 12 (60) |
Surgeries | |
 Resection | 5 (25) |
 Colectomy | 3 (15) |
 Stoma | 2 (10) |
Smoking history | |
 Current smoker | 3 (15) |
 Previous smoker | 5 (25) |
 Non-smoker | 12 (60) |
Pain locations | |
 Abdomen | 18 (85) |
 Joints | 14 (70) |
 Back | 13 (65) |
 Head | 8 (40) |
Pain medications | |
 Paracetamol | 10 (50) |
 Co-codamol | 4 (20) |
 Opioids | 10 (50) |
 Pregabalin | 1 (5) |
 NSAIDs | 3 (15) |
 Tricyclic antidepressants | 3 (15) |
 Antispasmodics | 1 (5) |
 Omeprazole | 1 (5) |
 Benzodiazepine | 1 (5) |
 Other (anti-diarrhoeal, anti-bile acid) | 0 (0) |